In March 2023, CLM team members met a woman living with HIV in a sero-discordant relationship. After living together for about 4 years, her husband started abusing her mentally and physically due to her HIV positive status. She was disowned by her husband and forced out of her home, but was not granted a legal […]
Author: admin
Listening to community and enabling procurements
On 29 May 2023, Peduli Hati, the Director General of Pharmaceutical and Medical Devices, and representatives of the Communication and Public Service Bureau and the Indonesian CDC discussed procurement of additional hepatitis C medicines and rapid molecular testing machines using the national Global Fund budget. Action taken: By July 2023, there was an agreement to procure […]
Stock out of HCV medicines resolved
After a protest rally on 29 May 2023 on the need to create access to hepatitis C treatment, the government procured daclatasvir through an emergency purchase mechanism the next day on 30 May 2023. Action taken: On 31 May 2023 the Hepatitis Working Team, Peduli Hati and the Provincial Health Office conducted a coordination meeting […]
TREAT Asia: Hepatitis B issue brief
TREAT Asia releases Issue brief titled Hepatitis B: A Hidden Public Health Emergency in the Asia-Pacific. Our CLM work also includes monitoring hepatitis B services. Please see the tools page for the indicators and dashboard to understand the services and its quality.
TREAT Asia Launches Community-led Monitoring Dashboard
amfAR’s TREAT Asia program has launched CLM Asia, an online data dashboard to enhance ongoing community-led monitoring in India and Indonesia. The dashboard is a central component of a three-year-old CLM project that was initiated by TREAT Asia and three partner organizations.
DAA stock-out protest rally in Jakarta
Indonesia has been experiencing stock-outs of the hepatitis C medicine daclatasvir since April 2023. Through their community-led monitoring (CLM) program documenting delivery of viral hepatitis care and treatment services, Peduli Hati previously identified several shortages of hepatitis C medicines, which were rapidly resolved after advocacy meetings with the Indonesian Ministry of Health. However, due to […]
Analysis of Community Treatment Observatory Data for HIV and Hepatitis C Virus Services in India and Indonesia
amfAR’s TREAT Asia program and three partner organizations initiated two Community Treatment Observatories (CTOs) to assess availability, accessibility, acceptability and quality of services for HIV and Hepatitis C (HCV) in India and Indonesia. It is hoped that the resulting analysis, available here, will help inform and advance advocacy priorities aimed at improving and expanding access […]